Prem Thurairajah, MBBS, MRCP, PhD
Doctor of Philosophy, PhD
Advance Fellowship Queen Elizabeth Hospital, University Hospital of Birmingham, United Kingdom Transplant Hepatology
University College of London, United Kingdom Hepatolbiliary Endoscopy
Clinical Interests and Expertise
Immunogenetics of Hepatitis C Resistance
Warshow UM, Riva A, Hegazy D, Thurairajah PH, Kaminski ER, Chokshi S, Cramp ME. Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection. J Viral Hepat. 2012 Jul;19(7):501-8.
Singh R, Nordeen N, Shanmuganathan G, Thurairajah PH, Bhat YM. Role of narrow band imaging in Barrett's esophagus. Dig Endosc. 2011 May;23 Suppl 1:83-5.
Thurairajah PH, Hegazy D, Demaine A, Kaminski ER, Cramp ME. Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation. J Infect Dis. 2011 Mar 15;203(6):847-53.
Thurairajah P, Khanna A, Mutimer D. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus (J Viral Hepat 2010 Feb 1;17(2):123-9). J Viral Hepat. 2011 Nov;18(11):820.
Thurairajah PH, Hegazy D, Chokshi S, Shaw S, Demaine A, Kaminski ER, Naoumov NV, Cramp ME. Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection. J Infect Dis. 2008 Dec 15;198(12):1749-55.
|Comments and Corrections | An Equal Opportunity University | Jobs | Terms, Conditions and Accessibility Statements | Privacy|
© 2012, University of Kentucky College of Medicine, 138 Leader Ave., Lexington, Kentucky, USA 40506-9983
Student Affairs: (859) 323-5261 · Admissions: (859) 323-6161 · Clinical Questions: (859) 257-1000 · Dean's Office: (859) 323-6582
Page last updated Tuesday, November 05, 2013